IntermediaterespiratoryPhysiology
Surfactant: The Soapy Film That Keeps Alveoli Open
Overview
Surfactant is a phospholipid-protein mixture secreted by type II alveolar cells that reduces surface tension at the air-water interface in alveoli. Without it, the tiny alveoli would collapse (Laplace's law) and inflation would require enormous work. Surfactant production matures late in fetal development, which is why premature infants can develop respiratory distress syndrome.
Learning objectives
- Explain the surface-tension problem in alveoli
- State Laplace's law and its implication for small alveoli
- Describe surfactant composition and its source
- Explain how surfactant stabilizes alveoli of different sizes
- Describe respiratory distress syndrome of the newborn
Process steps
Each alveolus has a thin aqueous lining. At any air-water interface, water molecules attract each other, creating surface tension that tries to shrink the surface - like the skin on a soap bubble resisting expansion.
Laplace's law states that collapsing pressure equals 2 x surface tension divided by radius (P = 2T/r). Smaller alveoli generate higher collapsing pressures, so without intervention small alveoli would empty into larger ones and collapse.
Type II pneumocytes secrete surfactant - mainly the phospholipid dipalmitoylphosphatidylcholine (DPPC) plus surfactant proteins - which spreads as a monolayer over the alveolar lining fluid.
The phospholipid molecules wedge between water molecules at the interface, greatly reducing their attraction and thus surface tension - cutting the work of inflation roughly two-thirds.
Surfactant is dynamic: as an alveolus shrinks during expiration, surfactant molecules pack tighter and surface tension falls further, preventing collapse; as it expands, they spread and tension rises, preventing overexpansion. This size-dependent behavior stabilizes the whole population.
Surfactant production surges in the final weeks of pregnancy. Premature birth before adequate production causes neonatal respiratory distress syndrome: stiff lungs, collapsing alveoli, and exhausting work of breathing.
Key variables
| Variable | Unit | Typical range | Role |
|---|---|---|---|
| Surface tension reduction | relative | Greatly reduced | Surfactant cuts inflation work by roughly two-thirds |
| Laplace collapsing pressure | formula | P = 2T/r | Smaller radius means higher collapse pressure at equal tension |
| Surfactant main lipid | molecule | DPPC | Dipalmitoylphosphatidylcholine, the key phospholipid |
| Type II cell share | percent of alveolar cells | About 5-10 | Few in number but vital in function; also repair type I cells |
| Surfactant maturation | gestational timing | Late third trimester | Surge in final weeks; deficiency causes RDS in prematurity |
Feedback loops
Breathing turnover positive feedback
- Ventilation stretches alveoli cyclically
- Type II cells sense stretch and secrete surfactant
- Surface tension stays low
- Easy inflation continues
Collapse prevention negative feedback
- An alveolus begins to shrink
- Surfactant concentrates; surface tension plummets
- Collapsing pressure falls
- The alveolus stays open
The surface-tension problem
Water's surface tension would make alveoli behave like tiny bubbles trying to collapse - and by Laplace's law (P = 2T/r), the smallest would collapse first and hardest. With ~480 million alveoli averaging ~0.2 mm diameter, the total collapsing force without surfactant would make breathing impossibly laborious.
Collapsing pressure = 2 x surface tension / radius. Halve the radius, double the collapse pressure - small alveoli are the most vulnerable.
Surfactant: composition and source
Type II alveolar cells (great alveolar cells) manufacture and secrete surfactant: ~90 percent lipids (chiefly DPPC) and ~10 percent proteins (SP-A, B, C, D). The proteins help spread, stabilize, and recycle the film and contribute to innate immunity - surfactant is more than soap.
Type II cells reclaim and recycle used surfactant components, turning over the alveolar pool efficiently.
Dynamic stabilization
Surfactant's genius is its concentration-dependence: compression during expiration packs molecules tighter, lowering tension most when collapse threatens; expansion spreads them, raising tension to brake overinflation. One film thus both prevents collapse of small alveoli and prevents rupture of large ones - automatic size stabilization.
Neonatal respiratory distress is a clinical emergency; this lesson covers the underlying physiology.
Work of breathing
Surface tension normally accounts for about two-thirds of lung elastic recoil. By slashing it, surfactant dramatically reduces the muscular work of each breath - and keeps the lungs compliant (~200 mL/cmH2O). Its loss makes lungs stiff and breathing exhausting, the mechanical core of respiratory distress.
Respiratory distress syndrome
Premature infants born before the late-gestation surfactant surge develop RDS: widespread alveolar collapse (atelectasis), stiff noncompliant lungs, and hypoxemia. Treatment includes exogenous surfactant replacement and supportive ventilation - one of neonatology's great success stories, built directly on this physiology.
Key points
- Surfactant reduces alveolar surface tension, cutting inflation work ~two-thirds.
- Laplace's law (P = 2T/r) makes small alveoli most collapse-prone.
- Type II pneumocytes secrete the DPPC-rich surfactant film.
- Tension falls as alveoli shrink, automatically preventing collapse.
- Late-gestation maturation explains premature RDS.
Common misconceptions
✓ Truth: Adults continuously secrete and recycle surfactant; its loss (e.g. in ARDS) causes alveolar collapse and stiff lungs at any age.
✓ Truth: Alveoli vary in size, and without surfactant's dynamic tension adjustment, small ones would progressively empty into large ones.
✓ Truth: Surface tension always promotes collapse. Surfactant's entire job is to oppose it - tension is the enemy, not the ally.
Practice questions
Q1. Pulmonary surfactant is secreted by:
- Type I pneumocytes
- Type II pneumocytes
- Goblet cells
- Clara cells
Type II (great alveolar) cells synthesize, secrete, and recycle surfactant; they also regenerate type I cells.
Q2. According to Laplace's law, the alveoli most prone to collapse are the:
- Largest
- Smallest
- Most ventilated
- Uppermost
P = 2T/r: smaller radius means higher collapsing pressure at the same surface tension.
Q3. Surfactant reduces the work of breathing by:
- Strengthening alveolar walls
- Reducing surface tension at the air-water interface
- Increasing lung volume
- Paralyzing the diaphragm
Lower surface tension means less pressure is needed to inflate alveoli - roughly two-thirds less elastic work.
Q4. Neonatal respiratory distress syndrome is caused by:
- Excess surfactant
- Surfactant deficiency from premature birth
- Maternal antibodies
- Too much oxygen
Birth before the late-gestation surfactant surge leaves alveoli unprotected against surface-tension collapse.
Click a question to reveal the answer and explanation.
Frequently asked questions
What is surfactant made of?
Mostly phospholipids - chiefly dipalmitoylphosphatidylcholine (DPPC) - plus about 10 percent surfactant proteins (SP-A, B, C, D) that aid spreading, stability, recycling, and immune defense.
How does surfactant prevent alveolar collapse?
It inserts between water molecules at the air-liquid interface, reducing surface tension. As an alveolus shrinks, surfactant concentrates and tension falls further - exactly countering Laplace's rising collapse pressure.
Why do premature babies get respiratory distress syndrome?
Surfactant production surges late in gestation. Birth before adequate production leaves alveoli surfactant-deficient: they collapse, lungs stiffen, and breathing becomes exhausting with poor oxygenation.
What does Laplace's law say about alveoli?
Collapsing pressure equals twice the surface tension divided by radius (P = 2T/r): smaller alveoli face higher collapsing pressures, so they need surfactant's protection most.